GeneDx Holdings (WGS) Other Non-Current Assets (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Other Non-Current Assets of $4.3 million for Q1 2026, up 0.71% year-over-year from $4.3 million in Q1 2025, and down 0.74% quarter-over-quarter from $4.3 million in Q4 2025.
GeneDx Holdings (WGS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Other Non-Current Assets for 7 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 0.71% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (up 0.71% YoY), while the FY2025 annual figure was $4.3 million, changed 0.23% from the prior year.
- Other Non-Current Assets slipped to $4.3 million in Q1 2026 per WGS's latest filing, from $4.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $13.5 million in Q3 2022 and bottomed at $900000.0 in Q2 2023.
- Historically, Other Non-Current Assets has averaged $5.8 million across 5 years, with a median of $4.4 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 720.56% — and 2023, when it sank 88.56%.
- GeneDx Holdings' Other Non-Current Assets stood at $7.4 million in 2022, then tumbled by 40.24% to $4.4 million in 2023, then retreated by 2.42% to $4.3 million in 2024, then advanced by 0.23% to $4.3 million in 2025, then fell by 0.74% to $4.3 million in 2026.
- Business Quant data shows WGS's Other Non-Current Assets at $4.3 million in Q1 2026, $4.3 million in Q4 2025, and $4.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 49.99 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 567.73 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 769.30 Mn |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn | 4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28 Mn |
| Mar 31, 2026 | 4.28 Mn |
| Dec 31, 2025 | 4.32 Mn |
| Sep 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 13.04 Mn |
| Dec 31, 2022 | 7.39 Mn |
| Sep 30, 2022 | 13.50 Mn |
| Jun 30, 2022 | 14.37 Mn |
| Mar 31, 2022 | 6.95 Mn |
| Dec 31, 2021 | 6.93 Mn |
| Sep 30, 2021 | 3.61 Mn |